Cerephex To File Fibromyalgia Treatment 510(k) Within A Year
This article was originally published in The Gray Sheet
Executive Summary
Cerephex will file a 510(k) application within a year to treat fibromyalgia with its NeuroPoint non-invasive cortical stimulation device, the firm says